Bluebird Bio Inc. buy Barclays PLC
Start price
15.11.24
/
50%
€0.31
Target price
15.11.25
€1.90
Performance (%)
19.45%
End price
16.11.25
-
Summary
This prediction is currently being closed. The BUY prediction by Barclays_PLC currently has a performance of 19.45%. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bluebird Bio Inc. | - | - | - |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by Barclays_PLC for this prediction
In the thread Bluebird Bio Inc. diskutieren
bluebird bio, Inc. (NASDAQ: BLUE) had its price target lowered by analysts at Barclays PLC from $4.00 to $2.00. They now have an "overweight" rating on the stock.
Ratings data for BLUE provided by MarketBeat
In the thread Trading Bluebird Bio Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten